- Size
- 75 IU
- Purity
- 99.69%
- Formula
- Biological Preparation
Human menopausal gonadotropin is a purified preparation extracted from urine, containing both follicle-stimulating hormone and luteinising hormone activity in an approximately 1:1 ratio by international unit. It is not a synthetic peptide but a biologic — the gonadotropins in it are glycoprotein heterodimers sharing a common alpha subunit with a hormone-specific beta subunit, and the preparation carries a small contribution of chorionic gonadotropin that accounts for part of the labelled LH activity.
Its two activities act at different gonadal targets. FSH signals through the FSH receptor on granulosa cells in the ovary and Sertoli cells in the testis; LH acts at the LH/hCG receptor on theca and Leydig cells, driving steroidogenesis. Because a single preparation supplies both, hMG occupies a distinct position in the gonadotropin literature from recombinant FSH, which supplies FSH activity alone.
The history of these preparations is well documented: gonadotropin therapy developed from urinary extraction methods in the mid-twentieth century through successive purification generations, and comparative reviews have since evaluated urinary against recombinant preparations across large pooled study populations. Those comparative datasets, not manufacturer material, are the reference points cited on this page.
Categorised as Hormones — GH secretagogues, recombinant GH and gonadotropins.For research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any condition.